Bioprecariousness and vulnerability: An ethical approach to the issues of access to public health - 21/02/25
Highlights |
• | Vulnerability and health inequities are closely related. |
• | Bioprecariousness is an ethical concept defined as the structural violence against life due to the lack of access to essential products for life and health. |
• | The taxonomy of bioprecariousness divides it into pharmacological, digital and care-related. |
• | Bioprecariousness increases vulnerability and deepens health inequities. |
Abstract |
Introduction |
During the Covid-19 pandemics, the access to patented products (vaccines) become a problem of public health due to their high prices, especially in the least developed countries. Buth the concept of access is also related to other health care-related issues.
Objective |
This paper seeks to analyse these problems of access in public health by using the notion of bioprecariousness, that we generally define as the structural violence against life due to the lack of access to essential resources for life.
Methodology |
We shall analyse bioprecariousness by means of literature concerned to the concept of vulnerability, health disparities and IP legislation and shall assess the negative impact of bioprecariousness on global health equity.
Findings |
We shall present a taxonomy of bioprecariousness considering three different dimensions of health care in form of pharmacological, digital, and care-related bioprecariousness. From that point, we will explore the effects of each kind of bioprecariousness on public health, given that it increases vulnerability and health inequities simultaneously.
Conclusion |
Bioprecariousness is a concept closely related to vulnerability, which results in important health disparities and unjust distribution of health-related resources, thereby increasing health inequities. We propose to address the issues related to bioprecariousness by applying adequate government policies.
Le texte complet de cet article est disponible en PDF.Keywords : Big data, Bioprecariousness, Care, eHealth, Patents, Vulnerability
Plan
Vol 33
Article 101066- 2025 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?